Members of EBiSC are regularly participating in international conferences and symposia. If you want to learn more about EBiSC, we invite you to watch the videos available below. All videos below can also be found on your EBiSC playlist on YouTube.
We highlight how to identify and order lines of interest by refined searching and filtering the EBiSC online catalogue. Researchers wishing to leave a legacy and enable future R&D can learn from other scientists about the advantages of free-of-charge deposition while retaining legal ownership. The EBiSC 2 Innovation Showcase 2, ISSCR 2022, 17 June 2022. This presentation does not represent an endorsement from or support of the ISSCR
Leading EBiSC scientists focus on the wide range of EBiSC customer services. Scientists using EBiSC cell lines and customer services share insights about impacts on their research. EBiSC 2 Innovation Showcase 1, ISSCR 2022, 16 June 2022. This presentation does not represent an endorsement from or support of the ISSCR.
Mattias Hansson is Research Director at Novo Nordisk and responsible for upscaling operations at EBiSC. Meet him online and learn about his motivation, vision and work for making quality-controlled, disease-relevant iPSC lines available to researchers worldwide through EBiSC.
Rachel Steeg is Project Manager for Fraunhofer Institute for Biomedical Engineering that coordinates the EBiSC2 project. Meet him online and learn about his motivation, vision and work for making quality-controlled, disease-relevant iPSC lines available to researchers worldwide through EBiSC.
Bryan Bolton is Head of Business Development at Public Health England's European Collection of Authenticated Cell Cultures and responsible for banking and distribution at EBiSC. Meet him online and learn about his motivation, vision and work for making quality-controlled, disease-relevant iPSC lines available to researchers worldwide through EBiSC.
EBiSC Coordinator Dr. Andreas Ebneth (Janssen Pharmaceutica, Belgium) giving an introductory overview about the European Bank for induced pluripotent Stem Cells. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
EBiSC has developed an extensive range of high-quality, research-grade, and fully consented iPSCs which are available to academic and commercial scientists for use in disease modelling and other forms of pre-clinical research. The collection currently holds more than 800 iPSCs and is steadily growing.
Dr. Julia Neubauer (Fraunhofer IBMT, Germany) gives an overview and outlook on iPSC technical solutions for expansion and banking at scale.The EBiSC Final Workshop in Berlin, 2-3 November 2017.
Dr. Orla O'Shea from the National Institute for Biological Standards & Control (UK) about quality control developments for high throughput stem cell banking repositories. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
Applications of Stem Cell Biobanks: Prof. Dr. Christine Mummery (Leiden University Medical Center, NL) gives an overview on stem cell-based drug screenings for cardiovascular diseases. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
Dr. Ole Pless from the EBiSC project partner organisation Fraunhofer IME-SP (Germany) gives an overview on stem cell-based screening systems for drug discovery. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
Dr. Peter Harrison from the European Bioinformatics Institute at the European Molecular Biology Laboratory (UK) talks about setting up and handling a management and distribution system for large iPSC data. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
The EBISC project partner Prof. Andreas Kurtz (Charité, Germany) explains governance procedures for data and scientific quality of research-grade iPSC lines. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
The EBiSC project partner Dr. Bryan Bolton (European Collection of Authenticated Cell Cultures, UK) speaks about challenges and opportunities regarding worldwide distribution and long-term sustainability of cell line collections. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
Prof. Dr. Glyn Stacey (International Stem Cell Banking Initiative), former EBiSC partner at the UK Stem Cell Bank, about the development of QC systems for research & translation. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
The Project Coordinator, Dr. Timothy Allsopp (Pfizer Ltd.) gives an overview of the EBiSC project. EBiSC at the 2016 Annual Meeting of the International Society for Stem Cell Research (ISSCR) in San Francisco, 22-25 June 2016.
The EBiSC project partner Dr. Julie Holder (Roslin Cells Sciences, UK) speaks about the EBiSC experiences and challenges of building a European iPSC collection meeting research demand. EBiSC at the ISSCR Annual Meeting 2016 in San Francisco, 22-25 June 2016.
The EBiSC project partner Kevin Bruce (Roslin Cell Sciences, UK) about the challenges in building up EBiSC. The EBiSC Final Workshop in Berlin, 2-3 November 2017.
The EBiSC catalogue presented by the EBiSC project partner Laura Clarke from the European Bioinformatics Institute at the European Molecular Biology Laboratory (UK). EBiSC at the ISSCR Annual Meeting 2016 in San Francisco, 22-25 June 2016.
Prof. Glyn Stacey from the National Institute for Biological Standards & Control (UK) about EBiSC setting Quality Control standards to enhance iPSC research. EBiSC was present at the conference of the International Society for Stem Cell Research (ISSCR) in San Francisco, 22-25 June 2016.
Dr. Julie Holder (Roslin Cells Sciences, UK) about the EBiSC experience in establishing an unique ethical & legal governance structure for international iPSC banking. Recording of the EBiSC Focus Session at the ISSCR Annual Meeting 2016 in San Francisco (22-25 June 2016).
Dr. Ina Meiser from Fraunhofer IBMT presents the EU funded DropTech project and talks about the experience with EBiSC. Recording of the EBiSC Focus Session at the ISSCR Annual Meeting 2016 in San Francisco (22-25 June 2016).